NBC10’s Barbara Morse is sitting down with Dr. Eric Newton, the President of University Gastroenterology along with Renee Ambrose, the Clinical Director of Research. Together, they’re talking about ...

Crohn's disease, a type of inflammatory bowel disease (IBD), impacts millions worldwide. The disease is chronic and highly unpredictable, manifesting ...

A global consensus overrides fear of harming the fetus and makes some novel recommendations for the use of medication during ...

Researchers compare the different effects of pro-inflammatory dietary patterns on inflammatory bowel disease severity.

Some patients enrolled at Providence, R.I.-based University Gastroenterology have begun to see a clinical trial of ozaminod, 10 WJAR reported Oct. 8. The prospective phase 4, open-label study began in ...

New research has identified the pain pathways between the gut and brain Researchers have identified the nerve pathways ...

An Adelaide-based research collaboration has identified the specific nerve pathways responsible for relaying pain signals from the bowel to the brain, paving the way for new irritable bowel syndrome ...

A substantial number of patients with inflammatory bowel disease rely on cannabis and CBD oil for symptom relief, indicating a need for more rigorous investigation, according to a study published in ...

For patients with inflammatory bowel disease and obesity, bariatric surgery is associated with improved inflammatory bowel disease-related outcomes.

Roche’s Genentech unit has handed over $20 million in upfront cash for the license to Omass Therapeutics’ preclinical inflammatory bowel disease (IBD) program. | Roche’s Genentech unit has handed over ...

New research has uncovered why blood clotting malfunctions in IBD, and identified drugs that normalize blood clotting in human cells and animal models of IBD.